Fate Therapeutics, Inc.

General ticker "FATE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $281.5M (TTM average)

Fate Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -9.7%.

Estimated limits based on current volatility of 8.0%: low 0.98$, high 1.15$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Current price 27.0% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.47$, 4.04$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.29$, 3.47$]

Financial Metrics affecting the FATE estimates:

  • Negative: Non-GAAP EPS, $ of -1.51 <= 0.04
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -32.57 <= 1.79
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82

Similar symbols

Short-term FATE quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-120.70.80.911.11.21.31.41.5
Price $

Long-term FATE plot with estimates

12345678Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.4−0.3−0.2−0.10
FATES&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $96.30MM $63.53MM $13.63MM
Operating Expenses $404.69MM $254.04MM $223.91MM
Operating Income $-308.39MM $-190.51MM $-210.28MM
Non-Operating Income $26.66MM $24.55MM $22.38MM
R&D Expense $320.45MM $172.60MM $135.00MM
Income(Loss) $-281.72MM $-165.96MM $-187.90MM
Profit(Loss)* $-255.06MM $-160.93MM $-186.26MM
Stockholders Equity $483.94MM $368.42MM $318.73MM
Assets $705.56MM $506.22MM $440.69MM
Operating Cash Flow $-248.21MM $-132.26MM $-122.87MM
Capital expenditure $35.57MM $6.15MM $0.73MM
Investing Cash Flow $166.75MM $112.67MM $12.22MM
Financing Cash Flow $9.21MM $0.09MM $99.89MM
Earnings Per Share** $-2.63 $-1.64 $-1.64

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.